REGENCELL BIOSCIENCE HOLDING

Regencell Bioscience rises 4.8% to $10.05, 69% up month‑to‑date. 8.4M volume, 200‑day SMA at $18.44, 52‑wk high $69.00. See why the stock outpaces peers.

Regencell Bioscience (RGC) surges 4.8% as new gold‑bearing data from its Goldenclad site fuels investor optimism, while biopharma trials loom for future upside.